ImmuCell Corp
ICCC
NASDAQ
Biotechnology
$10.05
USD
-0.85 (-7.80%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $100.42M
Volume 92.0K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
ICCC | ImmuCell Corp | $100.42M | - | +9.6% | - | |
FBIO | Fortress Biotech Inc | $96.00M | 0.75 | +14.5% | +0.5% | |
GANX | Gain Therapeutics Inc | $94.49M | - | - | - | |
BMEA | Biomea Fusion Inc | $92.78M | - | - | - | |
RLYB | Rallybio Corp | $90.07M | - | +1.2% | - | |
ALDX | Aldeyra Therapeutics Inc | $86.87M | - | - | - | |
KLRS | Kalaris Therapeutics Inc | $84.74M | - | - | - | |
ACRV | Acrivon Therapeutics Inc | $74.48M | - | - | - | |
CTOR | Citius Oncology Inc | $68.57M | - | - | - |
Top Peer by Growth
Fortress Biotech Inc
+14.5% YoY Revenue
Lowest P/E Ratio
Fortress Biotech Inc
0.75x P/E
Best 1-Year Return
Rallybio Corp
+296.3% Return